Comparative study of local versus general anesthesia in video-assisted thoracoscopic surgery for empyema

Abstract

ObjectiveThis study evaluated the feasibility of performing non-intubated video-assisted thoracoscopic surgery (VATS) with local anesthesia for parapneumonic effusion and empyema resistant to conservative treatment. MethodsWe retrospectively reviewed 80 patients who underwent surgery for parapneumonic effusions and empyema between 2015 and 2021. Patients were divided into those who received non-intubated local anesthesia and general anesthesia during surgery. Patient demographics, characteristics, laboratory findings, treatment progress, and treatment outcomes were compared. The primary outcomes were duration of postoperative drainage, postoperative complication rate, and postoperative mortality rate within 30 days. ResultsAmong patients who received local (n = 21) and general anesthesia (n = 59), there was a significant difference in age (median 79.0 years [interquartile range (IQR) 77.0–80.0] vs. 68.0 years [IQR 54.5–77.5]; p < 0.001), preoperative performance status (3.0 [IQR 2.0–4.0] vs. 2.0 [IQR 1.0–3.0]; p < 0.001), and operative time (69 min [IQR 50–128] vs. 150 min [IQR 107–198]; p < 0.001) but not in preoperative white blood cell count (12,100/μL [IQR 8,400–18000] vs. 12,220/μL [IQR 8,950–16,724]; p = 0.840), C-reactive protein (15.2 mg/dL [8.8–21.3] vs. 17.9 mg/dL [IQR 9.5–23.6]; p = 0.623), postoperative drainage period (11 days [IQR 7–14] vs. 9 days [7–13]; p = 0.216), postoperative hospital stay (22 days [IQR 16–53] vs. 18 days [IQR 12–26]; p = 0.094), reoperation rate (9.5% vs. 15.3%; p = 0.775), postoperative complication rate (19.0% vs. 18.6%; p = 0.132), or postoperative 30-day mortality rate (4.8% vs. 0%; p = 0.587). ConclusionsVATS using local anesthesia is feasible for patients with treatment-resistant parapneumonic effusion and empyema with poor general condition.